Phosphatidylserine

Phosphatidylserine improves Concentration and Short Term Memory.

Phosphatidylserine effectively alleviates Depression - especially in elderly.

Phosphatidylserine increases brain Alpha Waves by 15-20%. 

Phosphatidylserine helps stabilize Brain Wave patterns in Epileptics.

Phosphatidylserine increases Intelligence.

Phosphatidylserine prevents the decline in Learning capacity that occurs with age. 

Phosphatidylserine prevents the decline in the number of brain dendrites that occurs with age.

Phosphatidylserine improves Mood (especially in elderly persons.)

Phosphatidylserine is involved in Myelin Sheath repair.

Phosphatidylserine increases the number of neurotransmitter receptor sites. 

Phosphatidylserine stimulates release of the brain neurotransmitter Dopamine.

Phosphatidylserine improves Reflexes [as judged by flicker-fusion response time].

Phosphatidylserine counteracts Cortisol that rises during intensive exercise and during stress.

Phosphatidylserine enhances the function of Nerve Growth Factor (NGF).

Phosphatidylserine increases production of the brain neurotransmitter acetylcholine.

Phosphatidylserine enhances brain glucose metabolism.

References

Crook, T. H., et al. Effects of phosphatidylserine in age-associated memory impairment. Neurology. 41(5):644-649, 1991.

Villardita, C., et al. Multicentre clinical trial of brain phosphatidylserine in elderly subjects with mental deterioration. Clinical Trials Journal. 24:84-93, 1987.

Crook, T., et al. Effects of phosphatidylserine in Alzheimer's. Psychopharmacol Bull. 28:61-66, 1992

Fungfield, E. W., et al. Double-blind study with phosphatidlyserine (PS) in Parkinsonian patients with senile dementia of Alzheimer's type (SDAT). Prog Clin Biol Res. 317:1235-1246, 1989.

Amaducci, L. Phosphatidylserine in the dosing of Alzheimer's disease: results of a multicenter study. Psychopharmacology Bulletin. 24:130-134, 1988.

Fungfield, E. W., et al. Double-blind study with phosphatidlyserine (PS) in parkinsonian patients with senile dementia of Alzheimer's type (SDAT). Prog Clin Biol Res. 317:1235-1246, 1989.

Delwaide, P. J., et al. Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurol Scandinavia. 73:136-140, 1986.

Amaducci, L., et al. Use of phosphatidylserine in Alzheimer's disease. Annals of the New York Academy of Sciences (USA). 640:245-249, 1991.

Engel, R. R., et al. Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type. Eur Neuropsychopharmacol. 2:149-155, 1992.

Palmieri, G., et al. Double-blind controlled trial of phosphatidylserine in patients with senile mental deterioration. Clinical Trials Journal (UK). 24(1):73-83, 1987

Gindin, J, et al. The Effect of plant phosphatidylserine on age-associated memory impairment and mood in the functioning elderly. Geriatric Institute for Education and Research, and Department of Geriatrics, Kaplan Hospital, Rehovot, Israel. 1995.